Reminder: NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through January 2022 Council

April 6, 2021

In recognition of the fact that COVID-19 may still be adversely affecting the ability of applicants to generate preliminary data, NIH will continue to accept a one-page update with preliminary data as post-submission materials for applications submitted for the January 2022 Council (beginning with applications submitted for the May 25, 2021 due date for Fall 2021 review meetings), ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application.

Reminder: NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through August/October 2021 Councils

January 13, 2021

In recognition of the fact that COVID-19 may still be adversely affecting the ability of applicants to generate preliminary data, NIH will continue to accept a one-page update with preliminary data as post-submission materials for applications submitted for the August/October 2021 council (beginning with applications submitted for the January 25, 2021 due date for Summer 2021 review meetings), ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application.

NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through August/October 2021 Councils

October 21, 2020

In recognition of the fact that COVID-19 may still be adversely affecting the ability of applicants to generate preliminary data, NIH will continue to accept a one-page update with preliminary data as post-submission materials for applications submitted for the August/October 2021 council (beginning with applications submitted for the January 25, 2021 due date for Summer 2021 review meetings), ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application.

Accepting Preliminary Data as Post-Submission Material and Other COVID-19-Related Application Flexibilities

June 9, 2020

As our nation looks to begin reopening, NIH continues to track how well our policies are meeting the evolving needs of the research community. In this post we would like to highlight allowance of preliminary data as a new special exception to our post submission materials policy and our guidance for reviewers.